Medicare Enrolled

Dr. Doreen Cassarino, ARNP

Physician Assistant · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1495 PINE RIDGE RD STE 4, Naples, FL 34109
2395945456
In practice since 2006 (19 years)
NPI: 1245266493 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cassarino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cassarino? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cassarino

Dr. Doreen Cassarino is a physician assistant in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cassarino performed 13,392 Medicare services across 6,621 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cassarino received a total of $35,136 from 51 pharmaceutical and/or device companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cassarino is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in FL$ $35,136 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,392
Medicare services
Top 1% in FL for physician assistant
6,621
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~705 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,920$18$47
Office visit, established patient (30-39 min)1,389$75$264
Blood draw (venipuncture)985$8$17
Comprehensive metabolic blood panel893$10$21
Lipid panel (cholesterol and triglycerides)839$13$27
Hemoglobin A1c test (diabetes monitoring)735$10$19
Thyroid stimulating hormone (TSH) test509$16$34
Complete blood count (CBC) with differential509$8$16
Vitamin D level test501$29$59
Vitamin B-12 level test500$15$30
Free thyroxine (T4) test315$9$18
Thyroid hormone, t3 measurement, free312$17$34
Annual wellness visit, follow-up304$111$267
Annual depression screening302$16$38
Urine microalbumin test (kidney screening)237$6$12
Creatinine test (kidney function)237$5$10
Ferritin level test (iron stores)214$13$27
Iron level test203$6$13
Iron binding capacity test203$9$17
Electrocardiogram (EKG), 12-lead197$8$30
Folic acid level test192$14$29
Automated urinalysis177$2$4
Drug injection, under skin or into muscle170$9$31
Injection, ketorolac tromethamine, per 15 mg160$0$1
Flu vaccine administration134$32$64
Flu vaccine, high-dose131$72$144
Glutamyltransferase (liver enzyme) level110$7$14
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous109$18$36
PSA test (prostate cancer screening)101$18$37
Urine culture, bacterial colony count92$8$16
Prostate cancer screening; prostate specific antigen test (psa)73$19$39
Office visit, established patient (20-29 min)59$48$187
Urinalysis, manual51$3$7
Urinalysis with microscopic exam49$3$6
Uric acid level test45$4$9
Injection, methylprednisolone sodium succinate, up to 125 mg44$4$11
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg44$1$3
Magnesium level test43$7$13
Pneumonia vaccine administration36$32$64
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use35$281$574
Transitional care management services for problem of high complexity33$186$570
Bacterial culture, aerobic29$8$16
Antibiotic sensitivity test29$8$17
New patient office visit (45-59 min)25$86$347
Basic metabolic blood panel21$8$17
Sed rate test (inflammation marker)20$3$5
C-reactive protein test (inflammation marker)18$5$10
Removal of impacted ear wax by washing16$13$32
Office visit, established patient, complex (40-54 min)14$113$371
Transitional care management services for problem of at least moderate complexity14$140$420
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit14$143$343
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$35,136
Total received (2021-2024)
Avg $8,784/year across 4 years
Top 1% in FL for physician assistant
51
Companies
821
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,275 (57.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,498 (38.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,363 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,002
2023
$4,749
2022
$7,916
2021
$11,469

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$11,282
AstraZeneca Pharmaceuticals LP
$9,923
Novo Nordisk Inc
$1,995
Bayer HealthCare Pharmaceuticals Inc.
$1,594
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,178
Lilly USA, LLC
$1,105
Bayer Healthcare Pharmaceuticals Inc.
$960
Amgen Inc.
$851
Abbott Laboratories
$678
Currax Pharmaceuticals LLC
$621
Xeris Pharmaceuticals, Inc.
$506
PFIZER INC.
$444
Janssen Pharmaceuticals, Inc
$307
Novartis Pharmaceuticals Corporation
$299
MannKind Corporation
$287
Amarin Pharma Inc.
$256
Corcept Therapeutics
$251
Dexcom, Inc.
$248
Exact Sciences Corporation
$206
Insulet Corporation
$188
GlaxoSmithKline, LLC.
$186
Merck Sharp & Dohme Corporation
$172
Tandem Diabetes Care, Inc.
$143
Esperion Therapeutics, Inc.
$135
Horizon Therapeutics plc
$125
ABBVIE INC.
$116
IBSA Pharma Inc.
$98
Zealand Pharma US, Inc.
$88
Merck Sharp & Dohme LLC
$88
Paratek Pharmaceuticals, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$66
Phathom Pharmaceuticals, Inc.
$56
Embecta Corp.
$56
DEXCOM, INC.
$53
Kowa Pharmaceuticals America, Inc.
$48
Biohaven Pharmaceuticals, Inc.
$47
ABIOMED
$41
Sunovion Pharmaceuticals Inc.
$41
BETA BIONICS, INC.
$39
Biohaven Pharmaceutical Holding Company Ltd.
$37
Medtronic, Inc.
$34
SANOFI PASTEUR INC.
$34
Mannkind Corporation
$32
Radius Health, Inc.
$24
Nevro Corp.
$21
Axonics, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$18
LIFESCAN, INC.
$18
OptiNose US, Inc.
$17
EISAI INC.
$17
Almatica Pharma LLC
$14
Top 3 companies account for 66.0% of total payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · ANORO ELLIPTA · ARCTIC FRONT ADVANCE · AREXVY · Aduhelm · Aimovig · Axonics · BAQSIMI · BD Nano 2nd Gen Pen Needle · BELSOMRA · BREZTRI · CITALOPRAM · CONTRAVE · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · EVKEEZA · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · Impella · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LICART · LIVALO · LOKELMA · Licart · Livalo · MOUNJARO · Minimed 630G · NEXLETOL · NURTEC ODT · NUZYRA · ONZETRA XSAIL · Omnia · Omnipod · Otezla · Ozempic · PRADAXA · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Proclaim IPG · QULIPTA · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLUJAN · SYNJARDY · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · VOQUEZNA · Vascepa · Wegovy · XARELTO · Xhance · ZEGALOGUE · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physician assistant and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for physician assistant in FL.

Equivalent to $262 per 100 Medicare services performed
Looking for a physician assistant in Naples?
Compare physician assistants in the Naples area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician Assistants within 10 mi
305
Per 100K population
78.7
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
3.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cassarino is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cassarino experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Cassarino performed 1,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cassarino receive payments from pharmaceutical companies?
Yes. Dr. Cassarino received a total of $35,136 from 51 companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cassarino's costs compare to other physician assistants in Naples?
Dr. Cassarino's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cassarino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →